3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Ganglioneuroblastoma
3
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Vaginal Neoplasms
1
Stomach Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Locally Advanced Cervical Adenocarcinoma
1
Infertility
1
Human Papillomavirus-Negative Neck Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biochemically Recurrent Prostate Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Congresses as Topic
×
1 year
×
Clear all
No trials found.